Preparation method and application of diosgenin derivatives containing 1,3,4 oxadiazole or 1,3,4 thiadiazole fragments

A technology of diosgenin and derivatives, which is applied in the field of natural medicine and medicinal chemistry, can solve the problems of large side effects and limited use, and achieve significant anti-lung cancer effect

Active Publication Date: 2022-02-01
QIQIHAR MEDICAL UNIVERSITY
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, although many anti-tumor drugs that have been marketed have good therapeutic effects, their side effects are large, which greatly limits their use. The research and development of anti-tumor drugs is facing severe challenges. The focus of the work of many researchers

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method and application of diosgenin derivatives containing 1,3,4 oxadiazole or 1,3,4 thiadiazole fragments
  • Preparation method and application of diosgenin derivatives containing 1,3,4 oxadiazole or 1,3,4 thiadiazole fragments
  • Preparation method and application of diosgenin derivatives containing 1,3,4 oxadiazole or 1,3,4 thiadiazole fragments

Examples

Experimental program
Comparison scheme
Effect test

specific Embodiment approach 1

[0025] Specific Embodiment 1: In this embodiment, diosgenin derivatives containing 1,3,4 oxadiazole or 1,3,4 thiadiazole fragments have a structural formula of R 1 It is an alkyl group containing 1 to 8 carbon atoms, an aromatic ring containing 5 to 12 carbon atoms, an alkoxy-substituted aromatic ring or an aromatic heterocyclic ring containing 5 to 12 carbon atoms, and the aromatic heterocyclic ring includes 1 to 3 heteroatoms of N, O or S, R 2 For H- or acetyl.

specific Embodiment approach 2

[0026] Specific embodiment two: the difference between this embodiment and specific embodiment one is: the R 1 is methyl, phenyl, p-methoxyphenyl, 1-naphthyl or 3-pyridyl.

[0027] Other steps are the same as in the first embodiment.

specific Embodiment approach 3

[0028] Specific embodiment three: the difference between this embodiment and specific embodiment one or two is: the preparation method of diosgenin derivatives containing 1,3,4 oxadiazole fragments is completed according to the following steps:

[0029] said Middle R 2 When it is an acetyl group, it is prepared according to the following steps: Diosgenin is in CH 2 Cl 2And react with acetic anhydride in pyridine solvent, obtain intermediate I, intermediate I is in CH 2 Cl 2 and glacial acetic acid by NaBH 3 CN was reduced to intermediate II, which was then oxidized by Jones reagent, tetrahydrofuran and acetone to intermediate III, followed by O-benzotriazole-N,N,N′,N′-tetramethylurea tetrafluoroborate As a coupling catalyst, N,N-diisopropylethylamine and dichloromethane, with acetylhydrazide, benzohydrazide, p-methoxybenzohydrazide, 1-naphthohydrazide or 3-pyridineformyl Hydrazine condensation to obtain intermediate IV; and then through POCl 3 Dehydration and cyclizati...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The preparation method and application of diosgenin derivatives containing 1,3,4 oxadiazole or 1,3,4 thiadiazole fragments relate to the technical fields of natural medicine and medicinal chemistry. The problem to be solved in the present invention is to find a diosgenin derivative containing oxadiazole and thiadiazole fragments with good antitumor activity. Method: Diosgenin in CH 2 Cl 2 React with acetic anhydride in pyridine solvent, CH 2 Cl 2 Reduction with glacial acetic acid, synthesis by oxidation, subsequent condensation, dehydration and ring closure, hydrolysis to obtain diosgenin derivatives containing 1,3,4 oxadiazole or 1,3,4 thiadiazole fragments; diosgenin derivatives It is used for the preparation of drugs for the treatment of tumor diseases. The invention can obtain the preparation method and application of diosgenin derivatives containing 1,3,4 oxadiazole or 1,3,4 thiadiazole fragments.

Description

technical field [0001] The invention relates to the technical field of natural medicine and medicinal chemistry, in particular to derivatives modified with the F ring of diosgenin. Background technique [0002] In recent years, the global cancer incidence and mortality are increasing rapidly, and cancer has become the second leading cause of death after cardiovascular and cerebrovascular diseases. According to the latest World Cancer Annual Report, from 2006 to 2016, the number of cancer deaths increased by 17.8%. In 2018, there were about 18 million new cases and 9.6 million cancer deaths worldwide. Malignant tumors have become an important killer of human health. However, although many anti-tumor drugs that have been marketed have good therapeutic effects, their side effects are large, which greatly limits their use. The research and development of anti-tumor drugs is facing severe challenges. focus of many researchers. [0003] Natural products have always been an impor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07J71/00A61P35/00
CPCC07J71/0005A61P35/00
Inventor 王文豹张金玲王雪梅杨吉芳郭丽娜孙辑凯王晓丽宋波
Owner QIQIHAR MEDICAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products